Lacavir-ET Tablet

Overview Lacavir-ET Tablet

Combivir-XR tablets combine antiretroviral medications to combat HIV (human immunodeficiency virus) infection. This treatment enhances the body's immune response to HIV, managing or treating AIDS (acquired immunodeficiency syndrome). Combivir-XR inhibits HIV replication, lessening the likelihood of HIV-related complications and extending lifespan. Optimal absorption requires taking the medication on an empty stomach, ideally before sleep. Consistent, timely dosing maximizes effectiveness; missed doses can hinder recovery. Complete the prescribed course as directed by your physician. Common side effects include drowsiness, vivid dreams, headaches, nausea, fatigue, nasal stuffiness, diarrhea, skin rashes, dizziness, insomnia, pain, depression, and cough. These usually subside within 2-4 weeks, but persistent or bothersome effects warrant medical attention. Drowsiness may impair driving ability; alcohol should be avoided due to potential side effect intensification. Pregnant or breastfeeding individuals, or those with kidney, liver, or other health issues, should consult their doctor before commencing treatment. Pre- and ongoing blood work, including liver and kidney function tests, may be recommended. Individuals with HIV should avoid breastfeeding and sharing personal items; safe sex practices are crucial to prevent HIV transmission.

Uses of Lacavir-ET Tablet

Managing HIV disease

Major Benefits of Lacavir-ET Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Lacavir-ET Tablets. Ingest the tablet whole; do not chew, crush, or divide it. Administer this medication on an empty stomach.

Common Side effects of Lacavir-ET Tablet:

• Headache
• Dizziness
• Nausea
• Insomnia (difficulty in sleeping)
• Weakness
• Depression
• Diarrhea
• Rash
• Pain
• Fever
• Decreased white blood cell count (neutrophils)
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Back pain
• Abdominal pain
• Anxiety
• Vomiting
• Joint pain
• Pneumonia
• Dyspepsia
• Muscle pain
• Lipodystrophy (skin thickening or pits at the injection site)
• Hypercholesterolemia (high cholesterol)
• Increased triglyceride level in blood
• Elevated creatinine kinase
• Elevated levels of serum amylase
• Blood in urine
• Increased transaminase level in blood
• Cough
• Impaired concentration
• Abnormal dreams

How to use Lacavir-ET Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lacavir-ET Tablet on an empty stomach.

How Lacavir-ET Tablet works:

Lacavir-ET tablets contain a triple antiviral blend of lamivudine, tenofovir disoproxil fumarate, and efavirenz. This combination inhibits HIV replication, lowering the viral load within the body. Concurrently, it elevates the CD4 T-cell count, strengthening the immune response.

What if you forget to take Lacavir-ET Tablet :

Should you forget a Lacavir-ET Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.